16:33 EST Arcutis Biotherapeutics (ARQT) files to sell common stock for holders, no amount given
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARQT:
- Arcutis Biotherapeutics reports Q4 EPS 13c, consensus 9c
- Arcutis announces Max Homa joins ‘Free to Be Me’ campaign
- ARQT Earnings this Week: How Will it Perform?
- Arcutis Buy Rating: Zoryve’s Strengthened Pediatric Data and Undervalued Long-Term Revenue Potential
- Arcutis Biotherapeutics announces results for Phase 2 trial of Zoryve